{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:18:26Z","timestamp":1788261506047,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Severe critical illness-induced immune suppression, termed immunoparalysis, is associated with longer duration of organ dysfunction in septic children. mRNA studies have suggested differential benefit of hydrocortisone in septic children based on their immune phenotype, but this has not been shown using a functional readout of the immune response. This study represents a secondary analysis of a prospectively conducted immunophenotyping study of pediatric severe sepsis to test the hypothesis that hydrocortisone will be differentially associated with clinical outcomes in children with or without immunoparalysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Children with severe sepsis\/septic shock underwent blood sampling within 48\u2009h of sepsis onset. Immune function was measured by quantifying whole blood ex vivo LPS-induced TNF\u03b1 production capacity, with a TNF\u03b1 response &lt;\u2009200\u2009pg\/ml being diagnostic of immunoparalysis. The primary outcome measure was number of days in 14 with MODS. Univariate and multivariable negative binomial regression models were used to examine associations between hydrocortisone use, immune function, and duration of MODS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred two children were enrolled (age 75 [6\u2013160] months, 60% male). Thirty-one subjects received hydrocortisone and were more likely to be older (106 [52\u2013184] vs 38 [3\u2013153] months,<jats:italic>p<\/jats:italic>\u00a0=\u20090.04), to have baseline immunocompromise (32 vs 8%,<jats:italic>p<\/jats:italic>\u00a0=\u20090.006), to have higher PRISM III (13 [8\u201318] vs 7 [5\u201313],<jats:italic>p<\/jats:italic>\u00a0=\u20090.0003) and vasoactive inotrope scores (20 [10\u201335] vs 10 [3\u201315],<jats:italic>p<\/jats:italic>\u00a0=\u20090.0002) scores, and to have more MODS days (3 [1\u20139] vs 1 [0\u20133],<jats:italic>p<\/jats:italic>\u00a0=\u20090.002). Thirty-three subjects had immunoparalysis (TNF\u03b1 response 78 [52\u2013141] vs 641 [418\u20131047] pg\/ml,<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.0001). Hydrocortisone use was associated with longer duration of MODS in children with immunoparalysis after adjusting for covariables (aRR 3.7 [1.8\u20137.9],<jats:italic>p<\/jats:italic>\u00a0=\u20090.0006) whereas no association with MODS duration was seen in children without immunoparalysis (aRR 1.2 [0.6\u20132.3],<jats:italic>p<\/jats:italic>\u00a0=\u20090.67).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Hydrocortisone use was independently associated with longer duration of MODS in septic children with immunoparalysis but not in those with more robust immune function. Prospective clinical trials using a priori immunophenotyping are needed to understand optimal hydrocortisone strategies in this population.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-020-03266-x","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:02:57Z","timestamp":1599217377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hydrocortisone treatment is associated with a longer duration of MODS in pediatric patients with severe sepsis and immunoparalysis"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-8075","authenticated-orcid":false,"given":"Katherine E.","family":"Bline","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Moore-Clingenpeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josey","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Greathouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Anglim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hanson-Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Nateri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Muszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Ramilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"issue":"5","key":"3266_CR1","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1164\/rccm.200207-682OC","volume":"167","author":"RS Watson","year":"2003","unstructured":"Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695\u2013701.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3266_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/PCC.0b013e3182917fad","volume":"14","author":"ME Hartman","year":"2013","unstructured":"Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med. 2013;14(7):686\u201393.","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"3266_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/PCC.0000000000002044","volume":"20","author":"K Typpo","year":"2019","unstructured":"Typpo K, Watson RS, Bennett TD, Farris RWD, Spaeder MC, Petersen NJ, et al. Outcomes of day 1 multiple organ dysfunction syndrome in the PICU. Pediatr Crit Care Med. 2019;20(10):914\u201322.","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"3266_CR4","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","volume":"21","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, et al. Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):e52\u2013e106.","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"3266_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1590\/1806-9282.62.06.482","volume":"62","author":"LF Darmaros","year":"2016","unstructured":"Darmaros LF, Delgado AF, Carvalho WB. Corticosteroids in septic shock: what should the decision in pediatrics be? Rev Assoc Med Bras (1992). 2016;62(6):482\u20134.","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"3266_CR6","doi-asserted-by":"crossref","unstructured":"Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC, et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med 2017;45(6):1061\u20131093.","DOI":"10.1097\/CCM.0000000000002573"},{"issue":"4","key":"3266_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","volume":"26","author":"PE Bollaert","year":"1998","unstructured":"Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26(4):645\u201350.","journal-title":"Crit Care Med"},{"issue":"2","key":"3266_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111\u201324.","journal-title":"N Engl J Med"},{"issue":"8","key":"3266_CR9","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1097\/01.CCM.0000080485.75448.45","volume":"31","author":"D Annane","year":"2003","unstructured":"Annane D, Briegel J, Keh D, Moreno R, Singer M, Sprung CL. Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone. Crit Care Med. 2003;31(8):2250\u20131 author reply 2-3.","journal-title":"Crit Care Med"},{"issue":"5","key":"3266_CR10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.jtcvs.2011.09.011","volume":"143","author":"TT Cornell","year":"2012","unstructured":"Cornell TT, Sun L, Hall MW, Gurney JG, Ashbrook MJ, Ohye RG, et al. Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2012;143(5):1160\u20136 e1.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"3266_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.injury.2007.08.041","volume":"38","author":"SK Tschoeke","year":"2007","unstructured":"Tschoeke SK, Ertel W. Immunoparalysis after multiple trauma. Injury. 2007;38(12):1346\u201357.","journal-title":"Injury"},{"key":"3266_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jcrc.2016.01.027","volume":"33","author":"TF Manzoli","year":"2016","unstructured":"Manzoli TF, Troster EJ, Ferranti JF, Sales MM. Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary intensive care unit. J Crit Care. 2016;33:84\u20139.","journal-title":"J Crit Care"},{"issue":"4","key":"3266_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SHK.0000000000000217","volume":"42","author":"JA Muszynski","year":"2014","unstructured":"Muszynski JA, Nofziger R, Greathouse K, Nateri J, Hanson-Huber L, Steele L, et al. Innate immune function predicts the development of nosocomial infection in critically injured children. Shock. 2014;42(4):313\u201321.","journal-title":"Shock"},{"issue":"10","key":"3266_CR14","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","volume":"44","author":"HR Wong","year":"2016","unstructured":"Wong HR, Atkinson SJ, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, et al. Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids. Crit Care Med. 2016;44(10):e1000\u20133.","journal-title":"Crit Care Med"},{"issue":"1","key":"3266_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2\u20138.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"3266_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/CCM.0b013e318267633c","volume":"41","author":"MW Hall","year":"2013","unstructured":"Hall MW, Geyer SM, Guo CY, Panoskaltsis-Mortari A, Jouvet P, Ferdinands J, et al. Innate immune function and mortality in critically ill children with influenza: a multicenter study. Crit Care Med. 2013;41(1):224\u201336.","journal-title":"Crit Care Med"},{"issue":"3","key":"3266_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1164\/rccm.201710-2006OC","volume":"198","author":"JA Muszynski","year":"2018","unstructured":"Muszynski JA, Nofziger R, Moore-Clingenpeel M, Greathouse K, Anglim L, Steele L, et al. Early immune function and duration of organ dysfunction in critically III children with sepsis. Am J Respir Crit Care Med. 2018;198(3):361\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3266_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37(3):525\u201332.","journal-title":"Intensive Care Med"},{"issue":"1 Pt 2","key":"3266_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.106.S1.205","volume":"106","author":"C Feudtner","year":"2000","unstructured":"Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics. 2000;106(1 Pt 2):205\u20139.","journal-title":"Pediatrics"},{"issue":"2","key":"3266_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","volume":"11","author":"MG Gaies","year":"2010","unstructured":"Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010;11(2):234\u20138.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"3266_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13613-016-0144-6","volume":"6","author":"A Villeneuve","year":"2016","unstructured":"Villeneuve A, Joyal JS, Proulx F, Ducruet T, Poitras N, Lacroix J. Multiple organ dysfunction syndrome in critically ill children: clinical value of two lists of diagnostic criteria. Ann Intensive Care. 2016;6(1):40.","journal-title":"Ann Intensive Care"},{"issue":"10","key":"3266_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","volume":"191","author":"SL Weiss","year":"2015","unstructured":"Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147\u201357.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3266_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/CCM.0000000000004123","volume":"48","author":"JJ Zimmerman","year":"2020","unstructured":"Zimmerman JJ, Banks R, Berg RA, Zuppa A, Newth CJ, Wessel D, et al. Trajectory of mortality and health-related quality of life morbidity following community-acquired pediatric septic shock. Crit Care Med. 2020;48(3):329\u201337.","journal-title":"Crit Care Med"},{"issue":"9","key":"3266_CR24","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","volume":"43","author":"SA Sterling","year":"2015","unstructured":"Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: a systematic review and meta-analysis. Crit Care Med. 2015;43(9):1907\u201315.","journal-title":"Crit Care Med"},{"issue":"6","key":"3266_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00134-008-1085-9","volume":"34","author":"CF de Oliveira","year":"2008","unstructured":"de Oliveira CF, de Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura AC, et al. ACCM\/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. 2008;34(6):1065\u201375.","journal-title":"Intensive Care Med"},{"issue":"7464","key":"3266_CR26","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/bmj.38181.482222.55","volume":"329","author":"D Annane","year":"2004","unstructured":"Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.","journal-title":"BMJ"},{"issue":"9","key":"3266_CR27","doi-asserted-by":"publisher","first-page":"e406","DOI":"10.1097\/PCC.0000000000001237","volume":"18","author":"B Nichols","year":"2017","unstructured":"Nichols B, Kubis S, Hewlett J, Yehya N, Srinivasan V. Hydrocortisone therapy in catecholamine-resistant pediatric septic shock: a pragmatic analysis of clinician practice and association with outcomes. Pediatr Crit Care Med. 2017;18(9):e406\u2013e14.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"3266_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/01.PCC.0000160596.31238.72","volume":"6","author":"BP Markovitz","year":"2005","unstructured":"Markovitz BP, Goodman DM, Watson RS, Bertoch D, Zimmerman J. A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care Med. 2005;6(3):270\u20134.","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"3266_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/PCC.0b013e3181fe4474","volume":"12","author":"JJ Zimmerman","year":"2011","unstructured":"Zimmerman JJ, Donaldson A, Barker RM, Meert KL, Harrison R, Carcillo JA, et al. Real-time free cortisol quantification among critically ill children. Pediatr Crit Care Med. 2011;12(5):525\u201331.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"3266_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092121","volume":"9","author":"HR Wong","year":"2014","unstructured":"Wong HR, Weiss SL, Giuliano JS Jr, Wainwright MS, Cvijanovich NZ, Thomas NJ, et al. The temporal version of the pediatric sepsis biomarker risk model. PLoS One. 2014;9(3):e92121.","journal-title":"PLoS One"},{"issue":"3","key":"3266_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","volume":"191","author":"HR Wong","year":"2015","unstructured":"Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191(3):309\u201315.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3266_CR32","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1097\/PCC.0000000000002338","volume":"21","author":"LS Srouji","year":"2020","unstructured":"Srouji LS, Moore-Clingenpeel M, Hensley J, Steele L, Greathouse K, Anglim L, et al. Shock severity modifies associations between RBC transfusion in the first 48 hours of sepsis onset and the duration of organ dysfunction in critically ill septic children. Pediatr Crit Care Med. 2020;21(8):e475\u2013e84.","journal-title":"Pediatr Crit Care Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-020-03266-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-020-03266-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T16:25:44Z","timestamp":1668615944000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-020-03266-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3266"],"URL":"https:\/\/doi.org\/10.1186\/s13054-020-03266-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board at Nationwide Children\u2019s Hospital in Columbus, OH.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any individual person\u2019s data in any form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Mark Hall is a consultant for La Jolla Pharmaceuticals. This work is unrelated to the content of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"545"}}